Blog Posts

Roberto Iacovelli

Mar 23, 2025, 09:00

Roberto Iacovelli: The surgical outcomes to neoadjuvant durvalumab in NIAGARA trial for NMIBC

Roberto Iacovelli, Medical oncologist at Gemelli Polyclinic Foundation IRCCS, shared a post on X:

“Prof Catto presented at EAU25 the surgical outcomes to neoadj. durvalumab in NIAGARA trial for NMIBC. No change for type, timiming and complications.”

More posts featuring Roberto Iacovelli.

cancer EAU25 NIAGARA trial NMIBC OncoDaily Oncology Roberto Iacovelli

Why Is Financial Wellness Crucial for Physicians and Health Care Professionals?

BOT/BAL Advancements, BATTMAN Trial, FDA Approval Challenges and Key Highlights from Agenus Stakeholder Briefing

10 Leading Experts Join OncoDaily Journal Editorial Team

Top 10 Oncogrants of the Week: Fueling Cancer Research and Innovation

Soon-Shiong’s “Bioshield” Sparks Early Promise in Recurrent GBM, With 2 Near-CRs and 100% Disease Control

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Insight

Aug 29, 2025, 15:47

Anirban Maitra Highlights Stereo-Seq V2 as a Game Changer in RNA Transcription Research

Voices

Aug 29, 2025, 15:38

Thor Halfdanarson Reflects on the Privilege of Clinical Medicine and Enjoying Nature

Voices

Aug 29, 2025, 15:30

Programme to Turn Knowledge Into Expertise and Refined Practical Skills - ESO

Science

Aug 29, 2025, 15:30

Katherine Van Loon Shared Impactful Commentary on Barriers to ICIs Access in Southeast Asia

Science

Aug 29, 2025, 15:21

Myeloma Paper of the Day, August 29th, Suggested by Robert Orlowski

Insight

Aug 29, 2025, 15:19

Sakditad Saowapa: Great Talks Ensure the Audience Leaves Knowing Something They Didn’t Before

Career Updates

Aug 29, 2025, 15:12

Vivek Ghosh: Beginning Clinical Fellowship at CancerCare Manitoba

Opinion

Aug 29, 2025, 15:06

Jason Binder: Precision Access or Pay-to-Play?

Voices

Aug 29, 2025, 15:00

Sara Tolaney Leads A012103 Trial to Compare Pembrolizumab to Observation in TNBC

Community

Aug 29, 2025, 14:53

Don't Forget to Submit Your Manuscripts to the Cancer Care in Europe Special Series by OncoDaily Medical Journal

Insight

Aug 29, 2025, 14:49

$500M Grant Powers Fred Hutch’s Fight Against Cancer - Tom Lynch

Insight

Aug 29, 2025, 14:48

Housing Aid Is Linked to Lower Medical Financial Hardship among U.S. Renters with Cancer